RaySearch's CEO Sells Shares - Remains a Long-term Shareholder
RaySearch's CEO Sells Shares - Remains a Long-term Shareholder
STOCKHOLM, Sept. 27, 2024 /PRNewswire/ -- RaySearch's founder and CEO, Johan Löf, has sold 150,000 Class B shares in RaySearch Laboratories AB (publ) on September 24, 2024. Johan Löf remains a long-term shareholder and after the transaction owns 5,443,084 Class A shares and 68,393 Class B shares, corresponding to 16.1 percent of the total number of shares and 52.8 percent of the total number of votes in the company.
2024年9月27日，瑞德尚（RaySearch）的创始人兼首席执行官Johan Löf于2024年9月24日出售了瑞德尚实验室Ab股份公司（publ）的15万B类股份。Johan Löf仍然是一位长期股东，在交易后拥有5,443,084个A类股份和68,393个B类股份，相当于公司总股份的16.1％和总投票权的52.8％。
Johan Löf, founder and CEO, RaySearch: "The sale is due to private financial reasons. I remain committed to the company with continued strong confidence in RaySearch's future. We are well positioned for continued growth, and I look forward to continuing to lead and develop RaySearch towards our strategic goals."
瑞德尚的创始人兼首席执行官Johan Löf表示：“出售是出于私人财务原因。我对瑞德尚的未来始终充满信心。我们已经为持续增长做好了充分准备，我期待继续领导和发展瑞德尚实现我们的战略目标。”
The transaction has been reported to the Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.
根据现行法规，此交易已向瑞典金融监管局（Finansinspektionen）报告。
ABOUT RAYSEARCH
关于 RAYSEARCH
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation* treatment planning system (TPS) and the oncology information system (OIS) RayCare*. The most recent additions to the RaySearch product line are RayIntelligence and RayCommand*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch Laboratories AB 是一家医疗技术公司，致力于开发创新软件解决方案，用于改善癌症治疗。RaySearch 推出了 RayStation* 治疗计划系统（TPS）和肿瘤信息系统（OIS）RayCare*。RaySearch 产品线的最新增加是 RayIntelligence 和 RayCommand*。RayIntelligence 是一款肿瘤学分析系统（OAS），可让癌症诊所收集、整理和分析数据。RayCommand 是一种治疗控制系统（TCS），旨在连接治疗设备、治疗计划和肿瘤信息系统。
RaySearch's software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RaySearch 的软件已销售给43个国家的1000多家诊所。该公司成立于2000年，是斯德哥尔摩卡罗琳斯卡学院的一个分支机构，自2003年起在纳斯达克斯德哥尔摩上市。更多信息请访问 raysearchlabs.com。
* Subject to regulatory clearance in some markets.
* 在一些市场上需要获得监管批准。
FOR MORE INFORMATION, PLEASE CONTACT:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
欲获得更多信息，请联系:
Johan Löf，RaySearch Laboratories Ab（publ）创始人兼首席执行官
电话：+46 (0) 8 510 530 00
[email protected]
Learn more about us on:
LinkedIn
YouTube
X
了解更多关于我们的信息：
LinkedIn
YouTube
X
This information was brought to you by Cision .
BORR钻探有限公司来源。
The following files are available for download:
以下文件可供下载：
|
RaySearch Press Release, September 27, 2024_ |
|
RaySearch新闻发布，2024年9月27日_ |
SOURCE RaySearch Laboratories
来源： RaySearch Laboratories
